logo

Summit Therapeutics Inc (SMMT) Stock: A 52-Week Tale of Drops and Gains

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Summit Therapeutics Inc’s current trading price is -50.87% away from its 52-week high, while its distance from the 52-week low is 692.86%. The stock’s price range for this period has been between $2.10 and $33.89 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 3.23 million for the day, a number notably higher than the average daily volume of 2.17 million over the last three months.

Summit Therapeutics Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $33.89 on 09/16/24, while the lowest price for the same period was registered at $2.10 on 05/28/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Summit Therapeutics Inc (SMMT) has experienced a quarterly decline of -16.54% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 12.27B and boasts a workforce of 105 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 19.25, with a change in price of +4.34. Similarly, Summit Therapeutics Inc recorded 4,057,312 in trading volume during the last 100 days, posting a change of +35.26%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for SMMT stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.01.

SMMT Stock Stochastic Average

As of today, Summit Therapeutics Inc’s raw stochastic average for the last 50 days stands at 3.13%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 6.15%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 32.50% and 49.81%, respectively.

SMMT Stock Price Performance Analysis

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. This year’s metric has recorded a Price decrease of -6.70%. However, over the past six months, we’ve seen a weaker performance of 75.82%. The price of SMMT leaped by -11.29% over the last 30 days. And in the last five days, it has fallen by -4.69%.

Most Popular